Can-Fite Reports 2023 Financial Results and Clinical Update
Ewopharma acquired marketing rights for namodenoson in the treatment of pancreatic carcinoma ...
Source: marketscreener.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Fite Broadens. Real-time updates on events, politics, business and more.